American Society of Clinical Oncology

SHERPA: White

People

  1. De Angelis
    De Angelis
  2. Gavrilovic
    Gavrilovic
  3. Kaley
    Kaley
  4. Mellinghoff
    Mellinghoff
  5. Nolan
    Nolan
  6. Pentsova
    Pentsova

Groups

  1. Department of Medicine (1)
  2. Dermatology Service (1)
  3. Dermatology (1)
  4. Division of Subspecialty Medicine (1)
  5. GSK Faculty (1)
  6. Human Oncology and Pathogenesis Program (1)
  7. Surgery (1)
  8. Survivorship Research (1)
  9. Tow Center for Developmental Oncology (TCDO) (1)
Search Within
  1. "Meeting abstract"
  2. "Antonio Omuro"
  3. "Elena Pentsova"
  4. "Dermatology"
Formats
  1. Meeting Abstract (1)
Groups
  1. Department of Medicine (1)
  2. Dermatology (1)
  3. Dermatology Service (1)
  4. Division of Subspecialty Medicine (1)
  5. GSK Faculty (1)
  6. Human Oncology and Pathogenesis Program (1)

More Groups

People
  1. Andrew Lassman (1)
  2. Antonio Omuro (1)
  3. Craig Nolan (1)
  4. Elena Pentsova (1)
  5. Eric Holland (1)
  6. Igor Gavrilovic (1)

More People

Years
  1. 2013 (1)
Publications
  1. Journal of Clinical Oncology (1)

Results (1)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I trial of temsirolimus (TEM) and perifosine (PER) for recurrent or progressive malignant glioma (MG)
    Meeting Abstract

    Kaley, T. J.; Pentsova, E.; Omuro, A. M. P.; Mellinghoff, I. K.; Nolan, C.; Gavrilovic, I. T.; DeAngelis, L. M.; Lacouture, M. E.; Holland, E. C.; Lassman, A. B.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save